A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
12/12/2025
BreakingDealsRefractiveSurgical
Alcon Raises Bid for STAAR Surgical; Large Shareholders Continue to Oppose Deal
Alcon reported Dec. 9 that it had amended its bid for phakic IOL maker STAAR Surgical, raising its offer to $30.75 per share in cash, up from $28 in August. The 9.8 increase did little to appease s...
12/12/2025
BreakingCataractGlaucomaRegulationRetinaSurgical
CMS Finalizes 2.6 Percent Increase for ASCs, HOPDs in 2026
The Centers for Medicare and Medicaid Services (CMS) has finalized a 2.6 percent increase in fees for ASCs and HOPDs in 2026, the agency reported Nov. 21. The percentage represents an average acros...
12/12/2025
BreakingClinical TrialCornealRegulation
US FDA Gives Green Light to Trial of EyeYon’s EndoArt Artificial Corneal Implant
Israel’s EyeYon Medical announced Dec. 8 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a trial of EndoArt, a syntheti...
12/12/2025
BreakingPresbyopiaRegulation
Lenz Partner Lotus Pharmaceutical Submits NDA in Korea for Vizz Presbyopia Drop
Lenz Therapeutics announced Dec. 1 that its partner Lotus Pharmaceutical had submitted a new drug application (NDA) to South Korea’s Ministry of Food and Drug Safety seeking marketing approval for ...
12/12/2025
BiosimilarsBreakingRegulationRetina
Santen to Market Bayer’s Authorized Eylea Biosimilar in Japan After Drug Gains Coverage
Bayer’s authorized biosimilar of Eylea (aflibercept) has secured reimbursement in Japan, according to an announcement from commercial partner Santen on Dec. 5. Bayer received approval of the biosim...
12/12/2025
BreakingClinical TrialGene TherapyRegulationRetina
US FDA Gives Green Light to Trial of Zhongmou’s Optogenetic Therapy for RP
China’s Zhongmou Therapeutics announced Nov. 27 that the US FDA had signed off on its investigational new drug (IND) application, allowing the company to proceed with a Phase I/II trial of ZM-02, t...
12/12/2025
BreakingIndustryRetina
Alkeus Appoints Retina Specialist Carlos Quezada-Ruiz, MD, as Chief Medical Officer
Alkeus Pharmaceuticals announced Dec. 2 that it had appointed retina specialist Carlos Quezada-Ruiz, MD, as chief medical officer. He succeeds Seemi Khan, MD, MPH, MBA, who has taken the role of ch...
12/12/2025
BreakingIndustryRetinaThyroid Eye Disease
Kriya Appoints Greg Di Russo, MD, as Chief Medical Officer
Kriya Therapeutics announced Dec. 1 that it had appointed Greg Di Russo, MD, as chief medical officer. The Durham, North Carolina, company has a pipeline of gene therapy candidates for chronic cond...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.